Taking this information into account, a CMA and NGS of the tumor DNA (estimated tumor infiltration – 30%) were performed, identifying the known germline BRCA1 variant with an AF of 35% and an additional NM_004985.5(KRAS_v001):c.35G>A variant with an AF of 23%. This evidence concerns the gene BRCA1 and neoplasm.